The Precision Peptide Company Inc. PNGAF
Set alert
0.23 USD +0.02 +10.30%
As of Nov 3, 11:37 AM ET
0.22 Day range 0.2353
0.0077 52-week range 0.4099
- YTD
- +9.50%
- 1 year
- -21.66%
- Open
- 0.2353
- Prev close
- 0.2049
- Mkt cap
- 12.57M
- Vol
- 11.40K
- Avg vol
- 37.93K
- EPS
- -0.15
- P/E
- 0.00
More statistics
- Low
- 0.22
- High
- 0.2353
2Y chart
Events in this range
- Feb 18, 2025Split: 1 for 6
Signals (83)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 5 days ago |
| RSI: Oversold | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 4, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 3 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 4 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
Newest 20 of 83.
News
- The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides
- The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas
- The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform
- The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line
- The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing
- RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
- The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
- The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers
- The Precision Peptide Company Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event
- The Precision Peptide Company Announces Grants of RSUs and Stock Options
Your note
Sign in to keep a note on PNGAF — it syncs with the Stock Master app.